首页 › 基金 › ACUTA CAPITAL PARTNERS, LLC › OCUL

ACUTA CAPITAL PARTNERS, LLC 对 OCUL 的持仓历史

OCULAR THERAPEUTIX INC · 医疗保健

ACUTA CAPITAL PARTNERS, LLC 在 Q3 2026 的 13F 申报中披露持有 OCUL(OCULAR THERAPEUTIX INC)574,543 股,市值约 US$4.4M,约占其申报组合的 3.48%,在其申报持仓中市值排名第 9 位。 ACUTA CAPITAL PARTNERS, LLC 最近 12 个申报季度中有 12 个季度披露了 OCUL 持仓,最早可追溯至 Q4 2023。

最新持仓 (Q3 2026)574.54K 股
申报持仓市值$4.41M
组合权重3.48%
首次申报Q4 2023
最近变动增持
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

ACUTA CAPITAL PARTNERS, LLC 对 OCUL 的持仓演变

ACUTA CAPITAL PARTNERS, LLC 于 Q4 2023 首次披露 OCUL 持仓:1,310,000 股(约 US$5.8M)。 该持仓在 Q1 2024 达到峰值 2,635,287 股,市值约 US$24.0M。 在 12 次申报中,ACUTA CAPITAL PARTNERS, LLC 5 次增持、6 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 574,543 股、市值约 US$4.4M,环比增持 42,062 股。。 持仓曾出现大幅变动:Q1 2024 增持约 101% (随后一个季度股价下跌 25%)、Q3 2024 减持约 57% (随后一个季度股价下跌 2%)、Q1 2026 减持约 44% (随后一个季度股价上涨 16%)。

逐季持仓明细

季度股数金额变化
Q4 2023 1.31M $5.84M 新进
Q1 2024 2.64M $23.98M 增持
Q2 2024 2.77M $18.95M 增持
Q3 2024 1.19M $10.35M 减持
Q4 2024 1.11M $9.49M 减持
Q1 2025 1.22M $8.94M 增持
Q2 2025 1.01M $9.42M 减持
Q3 2025 1.17M $13.62M 增持
Q4 2025 1.05M $12.78M 减持
Q1 2026 592.11K $5.02M 减持
Q2 2026 532.48K $5.23M 减持
Q3 2026 574.54K $4.41M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 OCUL 与 13F 数据

OCUL(OCULAR THERAPEUTIX INC)属于医疗保健行业。我们追踪的基金中还有 34 只申报持有 OCUL,申报仓位最大的包括:Deep Track Capital, LP (US$168.3M), Venrock Adviser, LLC (US$101.6M), SUMMER ROAD LLC (US$95.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 OCUL 的基金

查看 OCUL 的全部基金持有人 →

常见问题

How long has ACUTA CAPITAL PARTNERS, LLC held OCUL?

ACUTA CAPITAL PARTNERS, LLC has disclosed OCUL holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is ACUTA CAPITAL PARTNERS, LLC's current position in OCUL?

As of Q3 2026, ACUTA CAPITAL PARTNERS, LLC holds 574.54K shares of OCUL (OCULAR THERAPEUTIX INC), valued at $4.41M, representing 3.48% of its reported portfolio and ranking #9.

Has ACUTA CAPITAL PARTNERS, LLC been buying or selling OCUL?

In the latest 13F filing (Q3 2026), ACUTA CAPITAL PARTNERS, LLC increased its position in OCUL. The position peaked in Q1 2024 at 2.64M shares.

Which other funds hold OCUL?

Other major institutional holders of OCUL include Deep Track Capital, LP, Venrock Adviser, LLC, SUMMER ROAD LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.